DARMSTADT, GERMANY Merck now holds 22 CRISPR-related patents worldwide across nine different geographies Patents cover Paired Cas9 Nickase CRISPR genome-editing technology to advance gene therapy and research Merck, a leading science and technology company, today announced that the Japan Patent Office and the Intellectual Property Office of Singapore have each allowed the company’s patent application […]
AbCellera Biologics Inc., a global leader in therapeutic antibody discovery from natural immune systems, today announced that the U.S. Patent and Trademark Office (USPTO) has granted patent no. 10,466,241 titled “Methods for Assaying Cellular Binding Interactions.” The patent, exclusively licensed to AbCellera, originated from Carl Hansen’s former laboratory at the University of British Columbia and lists Carl […]
The proposed merger of 2 DNA sequencing system firms, Illumina and PacBio, raises competition concerns, an in-depth CMA review has provisionally found. The Competition and Markets Authority (CMA) has issued its provisional findings as part of a Phase 2 merger investigation of the proposed $1.2 billion takeover by Illumina, Inc. (Illumina) of Pacific Biosciences of […]
Newly Allowed Patent Covers use of the CertainT ® Platform in Cellulosic Fibers and Materials including Rayon; Company Currently in Discussions with Leading Manufacturers STONY BROOK, N.Y. – Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”) a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing for product authenticity and traceability solutions, announced today that […]
DeNovix Inc. announced today that the CellDrop™ Automated Cell Counter, the first imaging cell counter to operate without the need for slides or plastic consumables, has been granted Patent No. 6579475 by the Japanese Patent Office (JPO). WILMINGTON, DE — DeNovix Inc. announces the award of Japanese Patent No. 6579475 covering their innovation in the […]
SAN JOSE, Calif. – Complete Genomics, a U.S. affiliate of MGI, has filed a patent infringement counterclaim against Illumina in U.S. District Court for the Northern District of California. The lawsuit, filed September 30, alleges that Illumina and its customers are using various gene sequencers and related reagents, including NovaSeq 6000, HiSeq X Ten, HiSeq 3000, and HiSeq 4000, […]
HSINCHU, Taiwan – Personal Genomics Taiwan, Inc. (“PGI”), today announced that it has filed a complaint in the U.S. District Court for the District of Delawareagainst Pacific Biosciences of California, Inc. (“PacBio”). The complaint asserts that PacBio’s Sequel and Sequel II, as well as related commercialization activities by PacBio, infringe one or more claims of U.S. Patent No. 7,767,441 (the […]
Company has been issued 10 patents in 2019 for its single-cell technology and key applications Ann Arbor, Mich. — Celsee, Inc., today announced the issuance of U.S. Patent No. 10,416,070, entitled “Cell capture system and method of use,†which covers the automation of single-cell partitioning. Celsee has been issued ten patents by the U.S. Patent […]
HERCULES, Calif.–Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that it has filed a patent infringement suit against 10X Genomics, Inc. in the United States District Court for the District of Delaware. In the lawsuit Bio-Rad asserts that 10X Genomics infringes U.S. Patent […]
SOUTH SAN FRANCISCO, Calif. — Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that it has filed new legal action in the United States District Court for the Northern District of California seeking to stop the infringement of its patented technology by IONpath. In the complaint, Fluidigm alleges that […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
